Latest Health News

Vulcan Steel Limited reported a 12.6% revenue decline and a 64.8% drop in net profit for the first half of FY25 amid challenging market conditions. Despite this, the company achieved a 10% return on capital employed and is positioning itself for growth as economic recovery signs emerge.

Anagenics reports a marked reduction in operating cash outflow and expenses following a strategic restructuring, setting the stage for improved financial stability in the coming quarter.

Pro-Pac Packaging has updated its quarterly cash flow report, highlighting a net cash outflow from operations and outlining plans to improve margins and secure longer-term funding.

WAM Global reports a robust 23.7% increase in its investment portfolio for the year ending December 2024, prompting a rise in fully franked dividends including a special payout. The company’s strong financial results underscore its confidence in sustained growth and shareholder returns.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

WAM Global Limited has announced a special fully franked dividend of AUD 0.04 per share, reflecting strong profitability for the half-year ending December 2024. The dividend will be paid on July 31, 2025, with a Dividend Reinvestment Plan available to shareholders.

Micro-X Limited's trading suspension has been lifted following its announcement of an equity raising, signaling renewed market activity for the medical technology firm.

Keybridge Capital has been hit with an immediate $4.6 million loan repayment demand from Yowie Group, triggered by delays in its capital raising efforts obstructed by WAM Active Limited.

JB Hi-Fi Limited reported a robust 9.8% increase in HY25 sales to AUD 5.67 billion and an 8.0% rise in net profit, supported by its recent acquisition of e&s Trading Co. Despite strong momentum, the company remains cautious about competitive pressures ahead.

Mayne Pharma reports a robust first half of FY25 with revenues climbing to $210-$215 million and underlying EBITDA soaring by up to 300%, driven by strong performance in Women's Health.

Smartgroup has been appointed as the exclusive provider of salary packaging and novated leasing services for Monash Health’s 25,000 employees under a new multi-year contract starting April 2025.